Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a compounded veterinary medication. It is a liquid formulation where active ingredients are uniformly dispersed. This medication is used to manage conditions such as Cushing's Disease, Urinary Incontinence, Obesity, Hyperadrenocorticism, and Hypothyroidism in animals.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a compounded veterinary medication, specifically designed to treat a range of conditions in animals. This formulation is a liquid dosage form, where the active ingredient, phenylpropanolamine hydrochloride, is uniformly dispersed throughout a liquid medium. This ensures a homogeneous mixture, facilitating easy and accurate oral administration.
The medication is primarily used to manage conditions such as urinary incontinence, obesity, hyperactivity, certain types of allergies, and skin conditions in animals. The inclusion of a suspending agent in the formulation allows for the medication to be easily administered orally, ensuring optimal absorption and effectiveness.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is recognized as a appropriate treatment option for a variety of conditions in veterinary patients. However, it is crucial to adhere to the veterinarian's instructions when administering this medication. Close monitoring of the patient for any potential adverse reactions or side effects is also recommended to ensure the safety and well-being of the animal.
If you have any queries or require further information about Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet), or its application in treating specific disease states, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to assist and provide the necessary guidance.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a compounded formulation designed for veterinary use. It is primarily indicated for the treatment of urinary incontinence, obesity, and narcolepsy in dogs and cats. However, it may also be utilized for other conditions as determined by a professional veterinarian.
This medication is contraindicated in animals with known hypersensitivity to phenylpropanolamine or any of its components. It should not be administered to animals suffering from glaucoma, hypertension, or hyperthyroidism. It is crucial for pet owners to monitor their pets closely for any signs of adverse reactions, such as restlessness, agitation, or difficulty breathing. If any of these signs are observed, immediate contact with a veterinarian is strongly advised.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) should be kept out of reach of children and other pets to prevent accidental ingestion or misuse. It is also important to note that drug interactions may occur when phenylpropanolamine is used concurrently with other medications, such as monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, or other sympathomimetic agents. Therefore, pet owners should inform their veterinarian of any other medications their pet is currently taking before initiating treatment with phenylpropanolamine.
If you have any questions or concerns about the use of Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) or any other medication, please do not hesitate to reach out for further information and guidance.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a compounded medication designed to treat a range of conditions in animals. The medication functions by inhibiting the action of specific hormones in the body, such as epinephrine and norepinephrine, which can alleviate the symptoms associated with these conditions.
In the treatment of urinary incontinence, Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) operates by blocking the action of certain hormones in the body. This can help reduce the symptoms associated with this condition and decrease the volume of urine produced, thereby reducing the frequency of accidents.
For obesity management, Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) works by inhibiting the action of specific hormones in the body. This can help to suppress appetite and increase energy expenditure, leading to a reduction in food intake and promoting weight loss.
In the case of allergies, Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) works by blocking the action of certain hormones in the body. This can help to alleviate allergy symptoms, reduce the severity of allergic reactions, and decrease the need for additional medications.
It is crucial to adhere to your veterinarian's instructions when administering this medication. If you have any queries about how to use this medication, please consult with your veterinarian.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a versatile compounded formulation that can be used to manage a wide range of conditions. This formulation can also be used to alleviate the discomfort of motion sickness, making travel more comfortable for those affected.
Furthermore, Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) can be used to manage the symptoms of narcolepsy, helping to regulate sleep patterns and reduce daytime sleepiness. It is also beneficial in managing attention deficit hyperactivity disorder (ADHD), helping to improve focus and reduce hyperactivity.
For those suffering from depression, anxiety, or post-traumatic stress disorder (PTSD), this formulation can help to reduce symptoms and improve overall mental wellbeing. It can also be used to manage the symptoms of irritable bowel syndrome (IBS), providing relief from abdominal pain, bloating, and changes in bowel habits.
Lastly, Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) can be used to alleviate the symptoms of chronic fatigue syndrome (CFS), helping to improve energy levels and reduce fatigue. If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to contact us.
Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a compounded veterinary medication. It is a liquid dosage form where one or more ingredients are uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for administration.
This medication is administered orally. The uniform dispersion of the active ingredient in the liquid medium ensures that the correct dose is delivered with each administration.
The liquid medium serves as a vehicle for the active ingredient, Phenylpropanolamine HCl. It ensures that the active ingredient is evenly distributed throughout the solution, providing a consistent dose with each administration.
Phenylpropanolamine HCl is the active ingredient in this formulation. It is the component that provides the therapeutic effect of the medication.
Yes, Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet) is a homogeneous mixture. This means that the active ingredient is uniformly dispersed throughout the liquid medium.
This medication is specifically formulated for veterinary use. However, the suitability for animals other than dogs should be discussed with a veterinarian.
Liquid dosage forms are often easier to administer to animals than solid forms. They can be mixed with food or water, or given directly by mouth using a dropper or syringe.
Yes, the formulation process ensures that the Phenylpropanolamine HCl is uniformly dispersed throughout the liquid medium, providing a consistent concentration of 2.5 mg/ml.
Storage instructions for this medication should be provided by the pharmacist or veterinarian. It is important to follow these instructions to maintain the effectiveness of the medication.
If your pet has an adverse reaction to Phenylpropanolamine HCl 2.5 mg/ml Oral Suspension (Vet), you should contact your veterinarian immediately for advice.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally